Behnam Partopour serves as a Principal Scientist at Sartorius, where he plays a pivotal role in shaping the future of bioprocessing through his expertise in reaction engineering and fluid dynamics. With a solid foundation established during his PhD research, Behnam has honed his skills in...
Behnam Partopour serves as a Principal Scientist at Sartorius, where he plays a pivotal role in shaping the future of bioprocessing through his expertise in reaction engineering and fluid dynamics. With a solid foundation established during his PhD research, Behnam has honed his skills in mathematical modeling, thermodynamics, and process simulation, allowing him to tackle complex challenges in bioprocess design and optimization. His postdoctoral work at Amgen Inc. focused on developing predictive models for the commercial formulation of monoclonal antibodies, significantly enhancing the understanding of their physical properties and accelerating the development timeline.
At Sartorius, Behnam leads innovative research initiatives that drive the strategic direction of next-generation bioprocessing decisions. He is particularly focused on advancing the design and development of processes for monoclonal antibodies (mAbs), RNA therapeutics, induced pluripotent stem cells (iPSCs), chimeric antigen receptor T-cell (CAR-T) therapies, and viral processes. His dual approach encompasses building economic models that evaluate the cost efficiency, risks, uncertainties, and sustainability of future bioprocesses. By integrating machine learning and scientific computing techniques, Behnam is able to create robust simulations that inform decision-making and optimize bioprocess economics.
His work not only contributes to the efficiency and viability of biopharmaceutical production but also aligns with the industry's growing emphasis on sustainability and risk management. With a deep understanding of rigid body dynamics and molecular modeling, Behnam is at the forefront of bioprocess innovation, ensuring that Sartorius remains a leader in the rapidly evolving biopharmaceutical landscape. His commitment to advancing bioprocess design is evident in his collaborative efforts and thought leadership within the field, making him a key asset to the Sartorius team and the broader bioprocessing community.
